Lipid Management in Human Immunodeficiency Virus

被引:0
|
作者
Myerson, Merle [1 ,2 ]
机构
[1] Mt Sinai Roosevelt, Mt Sinai St Lukes, Inst Adv Med HIV, Cardiovasc Dis Prevent Program, New York, NY 10025 USA
[2] Mt Sinai Roosevelt, Mt Sinai St Lukes, Inst Adv Med HIV, Lipid Clin,Cardiol Sect, New York, NY 10025 USA
关键词
HIV; Dyslipidemia; Cardiovascular risk factors; Antiretroviral therapy; Infectious diseases; HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; LOW-DENSITY-LIPOPROTEIN; CARDIOLOGY/AMERICAN HEART ASSOCIATION; POLYUNSATURATED FATTY-ACIDS; EXTENDED-RELEASE NIACIN; 2013; AMERICAN-COLLEGE; CARDIOVASCULAR-DISEASE; LDL-CHOLESTEROL; FISH-OIL;
D O I
10.1016/j.ccl.2015.01.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of antiretroviral medications to treat patients infected with HIV has changed this disease from one that was fatal to a chronic and more manageable condition. However, these patients are at increased risk for cardiovascular disease due to the HIV itself, use of antiretroviral medications, and because they are living to an age when cardiovascular disease is more prevalent. At present there are no specific guidelines for management of risk factors, in particular dyslipidemia, for this patient population. We present recommendations based on those for the general population and how these may be applied to patients living with HIV.
引用
收藏
页码:277 / +
页数:23
相关论文
共 50 条
  • [21] Management of Human Immunodeficiency Virus Infection in Advanced Age
    Greene, Meredith
    Justice, Amy C.
    Lampiris, Harry W.
    Valcour, Victor
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (13): : 1397 - 1405
  • [22] Human immunodeficiency virus disease: Natural history and management
    Depaola, LG
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 2000, 90 (03): : 266 - 270
  • [23] Flow cytometry in the management of infection with human immunodeficiency virus
    Pinkerton, PH
    Rachlis, A
    Reis, MD
    Robinson, JB
    TRANSFUSION SCIENCE, 1995, 16 (04): : 321 - 332
  • [24] MANAGEMENT OF THE COMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    SAFRIN, S
    VOLBERDING, P
    ADVANCES IN INTERNAL MEDICINE, VOL 37, 1992, 37 : 133 - 152
  • [25] Management of the Metabolic Syndrome in Patients With Human Immunodeficiency Virus
    Feigenbaum, Kathryn
    Longstaff, Laura
    DIABETES EDUCATOR, 2010, 36 (03): : 457 - 464
  • [26] Intrapartum Management of Women With Human Immunodeficiency Virus Infection
    Wisner, Kirsten
    MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING, 2019, 44 (01) : 52 - 52
  • [27] Pharmacologic Management of Human Immunodeficiency Virus Wasting Syndrome
    Badowski, Melissa
    Pandit, Neha Sheth
    PHARMACOTHERAPY, 2014, 34 (08): : 868 - 881
  • [28] Complexity of human immunodeficiency virus management in developing countries
    White, AD
    Andrews, EB
    EPIDEMIOLOGY, 1998, 9 (06) : 593 - 595
  • [29] Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis
    Lederman, Michael M.
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (05) : 911 - 914
  • [30] Enhancing current human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C virus co-infection management
    Huang Zhan-Lian
    Chen Da-Biao
    Gao Zhi-Liang
    Lin Bing-Liang
    中华医学杂志英文版, 2020, 133 (23) : 2890 - 2891